Role of Inotropic Agents in the Treatment of Heart Failure
Key result
Clinician update reviews current inotrope options, patient selection, and risk mitigation strategies in HF.
Population
Patients with systolic heart failure
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Informs cautious inotrope selection in advanced HF; extends evidence synthesis but leaves open need for new RCTs.
Structured PICO
P
Population
Patients with systolic heart failure
I
Intervention
Inotropic agents
This clinician update reviews the current options, appropriate use, and risk mitigation strategies for inotropic therapy in patients with systolic heart failure.
Cite This Study
Goldhaber et al. (2010) conducted a review in Systolic heart failure. Inotropic therapy was evaluated. This clinician update discusses current options for inotropic therapy in heart failure, appropriate patient selection, and strategies to mitigate risks while maximizing benefits.